EP4125915
COMBINATION THERAPY WITH A MUTANT IDH INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.3.2021EP published:
17.4.2024EP application number:
21718410.0
EPO information:
European Patent Register
Max expiry date:
21.3.2041
Title in English:
COMBINATION THERAPY WITH A MUTANT IDH INHIBITORLanguage of the patent:
English
Timeline
Today
22.3.2021EP application
17.4.2024EP Publication
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
BROOKS, Nathan ArthurAddress:
Indianapolis, Indiana 46206-6288, US
Name:
GILMOUR, RaymondAddress:
Indianapolis, Indiana 46206-6288, US
Priority
Number:
202062993254 PDate:
23.3.2020Country:
US
Number:
202063024713 PDate:
14.5.2020Country:
US
Number:
202063053875 PDate:
20.7.2020Country:
US
Classification
Categories:
A61K 31/553, A61K 31/7068, A61K 31/706, A61K 31/5365, A61K 31/635, A61P 35/00, A61P 35/02